156 related articles for article (PubMed ID: 16844102)
1. Effect of alpha-tocopherol and deferoxamine on methamphetamine-induced neurotoxicity.
Park MJ; Lee SK; Lim MA; Chung HS; Cho SI; Jang CG; Lee SM
Brain Res; 2006 Sep; 1109(1):176-82. PubMed ID: 16844102
[TBL] [Abstract][Full Text] [Related]
2. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
Fukami G; Hashimoto K; Koike K; Okamura N; Shimizu E; Iyo M
Brain Res; 2004 Jul; 1016(1):90-5. PubMed ID: 15234256
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats.
Zhang X; Dong F; Mayer GE; Bruch DC; Ren J; Culver B
Neuroscience; 2007 Dec; 150(4):950-8. PubMed ID: 17988800
[TBL] [Abstract][Full Text] [Related]
4. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
Dluzen DE; McDermott JL; Darvesh AS
Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
[TBL] [Abstract][Full Text] [Related]
5. The effects of methamphetamine on the production of free radicals and oxidative stress.
Yamamoto BK; Zhu W
J Pharmacol Exp Ther; 1998 Oct; 287(1):107-14. PubMed ID: 9765328
[TBL] [Abstract][Full Text] [Related]
6. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
[TBL] [Abstract][Full Text] [Related]
7. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
8. Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines.
Burrows KB; Nixdorf WL; Yamamoto BK
J Pharmacol Exp Ther; 2000 Mar; 292(3):853-60. PubMed ID: 10688597
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine.
Suzer T; Coskun E; Demir S; Tahta K
Res Exp Med (Berl); 2000 Feb; 199(4):223-9. PubMed ID: 10743680
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum.
Theodore S; Cass WA; Maragos WF
Exp Neurol; 2006 Jun; 199(2):490-8. PubMed ID: 16510141
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
Kawasaki T; Ishihara K; Ago Y; Nakamura S; Itoh S; Baba A; Matsuda T
Eur J Pharmacol; 2006 Aug; 542(1-3):92-9. PubMed ID: 16784740
[TBL] [Abstract][Full Text] [Related]
12. Effects of lubeluzole on the methamphetamine-induced increase in extracellular glutamate and the long-term depletion of striatal dopamine.
Wallace TL; Vorhees CV; Gudelsky GA
Synapse; 2001 May; 40(2):95-101. PubMed ID: 11252020
[TBL] [Abstract][Full Text] [Related]
13. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
Liu B; Dluzen DE
Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine.
Wan FJ; Tung CS; Shiah IS; Lin HC
Eur Neuropsychopharmacol; 2006 Feb; 16(2):147-53. PubMed ID: 16061357
[TBL] [Abstract][Full Text] [Related]
15. The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
Koike K; Hashimoto K; Fukami G; Okamura N; Zhang L; Ohgake S; Koizumi H; Matsuzawa D; Kawamura N; Shimizu E; Iyo M
Neuropharmacology; 2005 Mar; 48(3):391-7. PubMed ID: 15721171
[TBL] [Abstract][Full Text] [Related]
16. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity.
LaVoie MJ; Card JP; Hastings TG
Exp Neurol; 2004 May; 187(1):47-57. PubMed ID: 15081587
[TBL] [Abstract][Full Text] [Related]
17. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice.
Dluzen DE
Neurosci Lett; 2004 Apr; 359(3):135-8. PubMed ID: 15050682
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress modulates membrane bound ATPases in brain regions of PCB (Aroclor 1254) exposed rats: protective role of alpha-tocopherol.
Sridevi N; Venkataraman P; Senthilkumar K; Krishnamoorthy G; Arunakaran J
Biomed Pharmacother; 2007 Aug; 61(7):435-40. PubMed ID: 17459649
[TBL] [Abstract][Full Text] [Related]
19. Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning.
Daberkow DP; Kesner RP; Keefe KA
Pharmacol Biochem Behav; 2005 May; 81(1):198-204. PubMed ID: 15894079
[TBL] [Abstract][Full Text] [Related]
20. Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity.
Buletko AB; Dluzen DE; McDermott JL; Darvesh AS; Geldenhuys WJ
Neurotoxicol Teratol; 2012; 34(3):338-43. PubMed ID: 22521941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
